Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.525 USD | -0.20% | -2.32% | +14.48% |
May. 20 | Standard BioTools Receives Shareholder Proposal from Madryn Asset Management | CI |
May. 08 | Tranche Update on Standard BioTools Inc.'s Equity Buyback Plan announced on March 1, 2024. | CI |
Business Summary
Number of employees: 537
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Consumables
39.3
%
| 47 | 47.8 % | 42 | 39.3 % | -10.80% |
Instruments
35.2
%
| 26 | 26.2 % | 37 | 35.2 % | +45.96% |
Service
24.4
%
| 24 | 24.2 % | 26 | 24.4 % | +9.56% |
Other
1.1
%
| - | - | 1 | 1.1 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
41.5
%
| 41 | 41.9 % | 44 | 41.5 % | +7.56% |
EMEA
34.0
%
| 33 | 33.8 % | 36 | 34.0 % | +9.25% |
China
14.9
%
| 11 | 11.5 % | 16 | 14.9 % | +39.82% |
Asia-Pacific
7.7
%
| 10 | 9.7 % | 8 | 7.7 % | -14.55% |
Americas
2.0
%
| 3 | 3.0 % | 2 | 2.0 % | -29.71% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Egholm
CEO | Chief Executive Officer | 61 | 22-04-03 |
Jeffrey Black
DFI | Director of Finance/CFO | 55 | 23-05-14 |
Shane Bowen
CTO | Chief Tech/Sci/R&D Officer | - | Jan. 04 |
Hanjoon Kim
COO | Chief Operating Officer | 53 | 22-04-03 |
Jeremy Davis
PRN | Corporate Officer/Principal | - | 22-06-11 |
Adam Taich
PRN | Corporate Officer/Principal | 49 | Jan. 04 |
Elizabeth Jensen
HRO | Human Resources Officer | 50 | 23-01-02 |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 22-03-31 | |
Fenel Eloi
BRD | Director/Board Member | 66 | 23-03-14 |
Kathy Hibbs
BRD | Director/Board Member | 60 | Jan. 04 |
Michael Egholm
CEO | Chief Executive Officer | 61 | 22-04-03 |
Eli Casdin
BRD | Director/Board Member | 51 | 22-04-03 |
Troy Cox
BRD | Director/Board Member | 60 | Jan. 04 |
Thomas Carey
CHM | Chairman | 62 | Jan. 04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 377,171,511 | 365,761,625 ( 96.97 %) | 7,251,000 ( 1.922 %) | 96.97 % |
Company contact information
Standard BioTools, Inc.
2 Tower Place Suite 2000
94080, South San Francisco
+650 266 6000
http://www.standardbio.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.48% | 936M | |
+7.87% | 219B | |
+11.83% | 192B | |
+18.87% | 142B | |
+30.03% | 111B | |
+2.09% | 65.32B | |
+14.15% | 52.45B | |
+2.68% | 49.8B | |
+6.60% | 43.43B | |
+1.85% | 35.95B |
- Stock Market
- Equities
- LAB Stock
- Company Standard BioTools Inc.